Dallas – October 14, 2026 -- Ten Taiwanese hospitals and health-tech companies used Taiwan Expo USA 2026 in Dallas to probe the U.S. market, arriving at stages ranging from seeking first partners to operating FDA-cleared products with American customers.
The Smart Healthcare Pavilion ran September 24–26 at the Kay Bailey Hutchison Convention Center. It was organized by the International Trade Administration (TITA) of the Ministry of Economic Affairs and implemented by the Taiwan External Trade Development Council (TAITRA). Exhibitors covered chronic-disease management, hospital AI, remote monitoring, elder care, medical computing and rehabilitation. Their shared hurdles were validation across patient populations, U.S. regulatory clearance, workflow fit and local deployment partners.
Health2Sync targets U.S. providers and payers with chronic-care data platform
Health2Sync (H2 Inc.) is still early in its U.S. expansion. It used Dallas to explore ties with primary-care providers, clinics, accountable care organizations, software platforms and payers. Its platform pairs a patient app with a cloud system for providers and uses AI to interpret home-generated behavioral data, including meal photos linked to glucose changes. Vice President of Business Development Erin Chung said patients with chronic diseases typically see doctors only once every two to three months.
Taiwanese hospitals seek U.S. data and partners to validate clinical AI
Taichung Veterans General Hospital (TCVGH) asks each of its 55 departments to run at least one AI project, said Deputy Superintendent Yuan-Hwa Chou. One system uses contactless facial analysis to assess pain and flag acute illness in emergency departments. TCVGH reported 86% specificity in identifying acute critical illness and is seeking validation in other healthcare settings. Chou said the hospital needs corporate collaborators to move beyond its own walls.
Chang Gung Memorial Hospital presented an AI system for HER2 FISH assessment in breast cancer. It analyzes cells across a broader slide area than manual review to account for tumor heterogeneity. The model was trained predominantly on Taiwanese data plus some Japanese cases, and the hospital said it lacks American and European data. The technology is patented in Taiwan, and its U.S. patent process is underway.
Onyx Healthcare expands a ten-year U.S. footprint, including VA facilities
Onyx Healthcare already has a substantial American presence, with equipment in U.S. hospitals including VA facilities. In Dallas it showed the Venus mobile nursing workstation, which combines computing, swappable batteries and configurable peripherals. It also showed Casper AI, a contactless system that uses environmental sensors to track movement, restlessness and bed exits and convert them into risk information for nursing teams, with no extra wearable.
VitalSigns starts first U.S. rollout in Texas after 2025 FDA clearance
VitalSigns Technology received U.S. FDA clearance for its device in 2025. Its first American rollout is underway in Texas through a local partner. The company is pursuing a further U.S. clearance for its software platform and developing post-discharge and hospital-at-home applications. CEO Rich Lee said that outside continuously monitored beds, "cardiac risk is always happening with or without you watching."